SEC
SlamSEC
SearchBrowseEarnings

Entrada Therapeutics, Inc.

Nasdaq:TRDA
Pharmaceutical Preparations·BOSTON, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

5 shown
FiledDescription
6/24/24
1.01
Material Agreement
→
11/1/23
1.01
Material Agreement
→
9/29/23
1.01
Material Agreement
→
12/8/22
1.01
Material Agreement
→
3/22/22
1.012.03
Material Agreement · New Debt Obligation
→
CEO
Doshi Dipal
CFO
Wentworth Kory James